AJCN Tufts Nutrition Symposium, Boston & Online Sept 2009
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tallkvist, J.
Right arrow Articles by Lönnerdal, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tallkvist, J.
Right arrow Articles by Lönnerdal, B.
Agricola
Right arrow Articles by Tallkvist, J.
Right arrow Articles by Lönnerdal, B.
American Journal of Clinical Nutrition, Vol. 72, No. 3, 770-775, September 2000
© 2000 American Society for Clinical Nutrition


Original Research Communications

Functional and molecular responses of human intestinal Caco-2 cells to iron treatment1,2,3,4

Jonas Tallkvist, Christopher L Bowlus and Bo Lönnerdal

1 From the Departments of Nutrition and Internal Medicine, University of California, Davis.

See corresponding editorial on page 677.

2 Presented in part at Experimental Biology ‘99, Washington, DC, 17–21 April 1999 (abstract LB205).

3 Supported in part by the Foundation of Henning and Johan Throne-Holst (JT).

4 Reprints not available. Address correspondence to B Lönnerdal, Department of Nutrition, University of California Davis, One Shields Avenue, Davis, CA 95616-8669. E-mail: bllonnerdal{at}ucdavis.edu.


    ABSTRACT
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
Background: Divalent metal transporter 1 (DMT1), HFE, and stimulator of iron transport (SFT) are transmembrane proteins that have been implicated in the regulation of iron homeostasis.

Objective: The objective of this study was to investigate whether absorption and transepithelial movement of iron correlated with gene expression of DMT1, HFE, and SFT in an experimental model of human absorptive enterocytes.

Design: Caco-2 cells were exposed to iron-supplemented media in either the presence or the absence of serum for 24, 72, and 168 h. At each time point, the uptake and transepithelial movement of iron were examined and gene expression of DMT1, HFE, and SFT was measured. Manganese and zinc absorption was also examined at 168 h.

Results: Iron treatment in the presence or absence of serum reduced the uptake and transepithelial movement of iron by {approx}50% after 72 and 168 h. No effect was observed at 24 h. The uptake and transepithelial movement of manganese were similar to those of iron at 168 h, whereas the effects on zinc were less pronounced. In the absence of serum, iron treatment was associated with a reduction of DMT1 expression by 50% at 72 and 168 h. HFE expression was dependent on serum, but iron treatment did not alter HFE expression. SFT expression was not affected by iron.

Conclusions: Iron treatment decreased cellular uptake of iron, manganese, and zinc, suggesting that these metals may utilize the same apical transporter. The transepithelial movement of iron and manganese, but not of zinc, was reduced across iron-treated Caco-2 cells, suggesting that iron and manganese are regulated by the same mechanism at the basolateral membrane. The gene expression of DMT1, HFE, and SFT did not fully correlate with the functional responses of Caco-2 cells. This may have been a result of posttranscriptional regulation of these genes or regulation of other genes involved in the uptake and transepithelial movement of iron in Caco-2 cells.

Key Words: Iron • manganese • zinc • intestinal absorption • Caco-2 cells • divalent metal transporter 1 • DMT-1 • HFE • stimulator of iron transport • SFT


    INTRODUCTION
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
Although it is well established that mammalian cells have an absolute requirement for iron, disturbances in the cellular handling of iron contribute to the pathogenesis of diseases such as hemochromatosis, Parkinson disease, diabetes mellitus, and cancer (14). Despite the prevalence of these disorders, the mechanism by which dietary iron is absorbed into the body is poorly understood. Recently, the identification of several novel genes that are involved in genetic disorders of iron metabolism has provided new insights into the regulation of iron movement across the intestinal epithelium.

Divalent metal transporter 1 (DMT1; also known as Nramp-2 and DCT1) is a transmembrane, proton-coupled transporter that is believed to be responsible for the transport of nonheme iron across the apical membrane of enterocytes. Duodenal expression of DMT1 is up-regulated by iron deficiency and hemochromatosis (58). Functional studies in Xenopus oocytes showed that DMT1 can mediate the uptake of various divalent metal ions, including iron, manganese, and zinc (5). It has also been suggested that DMT1 is responsible for iron transport across endosomal membranes (9).

Feder et al (1) reported a candidate gene for hereditary hemochromatosis that was identified by positional cloning and that encodes a novel major histocompatibility complex class I–like protein called HFE. In parenchymal cells, HFE interacts with the transferrin receptor (TfR) to inhibit the uptake of transferrin-bound iron (10, 11). The transport of iron across the basolateral membrane of enterocytes may also be regulated by HFE (1). Although the mechanism by which this occurs has not been determined, Waheed et al (12) proposed that HFE allows intestinal crypt cells to sense body iron stores and to program migrating enterocytes to absorb more or less dietary iron via DMT1.

Stimulator of iron transport (SFT) encodes a transmembrane protein that facilitates uptake of divalent and trivalent iron into RNA-microinjected Xenopus oocytes (13, 14). The nature of the SFT-mediated transport is similar to the uptake of non–transferrin bound iron (15), but the localization of SFT to endosomes suggests that SFT is also involved in transport of iron across intracellular membranes (13, 14). Experiments with human HeLa cells in vitro showed that SFT mRNA is up-regulated by iron depletion and down-regulated by iron supplementation (16). It was also shown that SFT is up-regulated in the liver of persons with hemochromatosis (16). The role of SFT in intestinal iron absorption has not been explored.

Although some insights have been made into the functions of these recently discovered genes, regulation of the expression of the genes in an experimental model of human absorptive enterocytes has not been well studied. Furthermore, how this regulation affects the absorptive process of iron and other essential minerals is unknown. In the present study, Caco-2 cells were treated with iron, and kinetic experiments were performed with iron, manganese, and zinc. DMT1, HFE, and SFT concentrations were measured to determine whether the expression of these genes correlated with changes in the kinetics of the metals. Experiments were performed in the presence and the absence of serum to determine whether serum factors influence gene expression and alter the cellular uptake and transepithelial movement of iron, manganese, and zinc. Intracellular iron concentration and TfR mRNA concentrations were measured to determine the effects of various treatments on cellular iron status.


    MATERIALS AND METHODS
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
Chemicals
59FeCl3 (specific activity: 0.14 GBq/mg Fe2+), 54MnCl2 (specific activity: 0.94 GBq/mg Mn2+), and 65ZnCl2 (specific activity: 0.04 GBq/mg Zn2+) were obtained from DuPont NEN (Boston). Nitrilotriacetic acid (NTA), fetal bovine serum (FBS), FeSO4 (7H20), and N-2-hydroxyethyl-piperazine-N'-ethanosulfonic acid (HEPES) were obtained from Sigma Chemical Company (St Louis). Cell culture media, antibiotics (penicillin and streptomycin), and Hank's Balanced Salt Solution (HBSS) were obtained from Gibco BRL through Life Technologies (Grand Island, NY).

Cells and media
The Caco-2 cells (American Type Culture Collection, Rockville, MD) were grown in minimum essential medium (MEM; Gibco, Rockville, MD) with Earle's salts (Gibco), L-glutamine, 10% FBS, and 1% penicillin and streptomycin at 37oC with 5% carbon dioxide. Cells between passages 45 and 50 were harvested at 80% confluence and split either into new tissue culture flasks (for gene expression studies) or onto permeable polycarbonate filters (for uptake and transepithelial movement studies) at a density of 225000/cm2. After 3 wk, the cells were treated for 24, 72, or 168 h with one of the following culture media: serum-free medium (MEM; 1 µmol/L Fe2+), iron-supplemented serum-free medium (MEM + Fe; 6 µmol/L Fe2+), serum-containing medium (MEM + FBS; 6 µmol/L Fe2+), or iron-supplemented serum-containing medium (MEM + FBS + Fe; 200 µmol/L Fe2+). Iron was supplemented as FeNTA4. The concentrations of iron in the media were determined by using inductively coupled axial plasma spectrometry (ICAP-AES) as described by Golub et al (17).

Intracellular iron
Caco-2 cells were seeded onto permeable polycarbonate filter supports and treated for 168 h with the various media as described above. The cells were rinsed 3 times with HBSS and the filters were gently cut from the supports. The cells were digested for 3 d in 3 mL ultrapure nitric acid at room temperature and then analyzed by using ICAP-AES. Filters without cells were treated as described above and used as background (n = 6/group).

Transport experiments
Experiments were carried out at 37oC in HBSS (pH 7.4) containing 25 mmol HEPES/L as described previously (18). Briefly, the Caco-2 cells were rinsed and incubated for 45 min with prewarmed HBSS. After preincubation, the HBSS was discarded and the filter supports with the monolayers were transferred to new wells containing 1.5 mL of 20 µmol/L human apotransferrin in HBSS; 0.5 mL HBSS containing 20 µmol 59Fe2+, 54Mn2+, or 65Zn2+/L and 2 mmol L-ascorbate/L was added to the apical chamber and the monolayers were incubated at 37oC for 3 h. At the end of the experiment, radioactivity in the basolateral chamber was measured by using ß- or {gamma}-spectrometry. The cumulative fraction (Frcum) of metal movement from the apical to the basolateral side of the monolayers versus time was determined according to the following equation:

where Cbli is the concentration of metal on the basolateral side at the end of the time interval i and Cap0 is the concentration of metal on the apical side at the beginning of the time interval.

To determine the amount of metal taken up into the cells during the 3 h of incubation, the monolayers were carefully rinsed with 1 mL ice-cold HBSS. The filters were removed and the Caco-2 cells were dissolved in 5 mL of 0.5 mol NaOH/L overnight; this was followed by ß- or {gamma}-spectrometry.

Assessment of monolayer integrity
The integrity of monolayers was confirmed by measuring the transepithelial electrical resistance with a Millicell Electrical Resistance System device (Millipore, Bedford, MA). Measurements were made before the transport experiments in HBSS, according to the method of Artursson et al (19). Monolayers with resistances <180 {Omega}/cm2 were not used in the experiments. Background resistance was determined by measuring the transepithelial electrical resistance across a filter without cells in HBSS.

Gene expression studies
Total RNA was isolated from Caco-2 cells by using the method of Chomczynski and Sacchi (20); 12 µg of total RNA per lane was loaded on a formaldehyde agarose gel. Hybridizations were performed at 68oC in Rapid-Hyb buffer (Amersham Pharmacia Biotech, Piscataway, NJ) according to the manufacturer's specifications and followed by washes at high stringency. Signal intensity was quantified by using phosphor imaging and IMAGEQUANT software (Molecular Dynamics, Sunnyvale, CA). Gene expression values were normalized for glyceraldehydes-3-phosphate dehydrogenase (GAPDH) expression and expressed in units relative to the control.

Probes
Human cDNA probes for DMT1, SFT, and GAPDH were generated by using reverse transcriptase-polymerase chain reaction with Caco-2 cell RNA as a template. Poly(A)+ RNA was isolated and reverse transcribed by using the Micro Fast Track kit (Invitrogen, Carlsbad, CA) and Superscript II reverse transcriptase (Life Technologies, Grand Island, NY). DMT1 primer sequences were 5'-TGTCACCGTCAGTATCCCAA-3' (forward) and 5'-GTGCAAT GCAGGATTCAATG-3' (reverse). This set of primers recognizes both iron response element (IRE) and non-IRE containing DMT1 transcripts. SFT primer sequences were 5'-TGGACATCTGCA TCTTCAGC-3' (forward) and 5'-TTAATTATCAGCCGGTTGG-3' (reverse). GAPDH primer sequences were 5'-GACCACAGTC CATGACATCACT-3' (forward) and 5'-TCC ACCACCCT GTTGCTGTAG-3' (reverse). The cDNA-probe for HFE was obtained by using polymerase chain reaction from human genomic DNA with primer sequences 5'-TGGCAAGGGTAAACAGATCC-3' (forward) and 5'-CTCAGGCACTCCTCTCAACC-3' (reverse). A 2-kb probe to human TfR was generated by using polymerase chain reaction from pCDTR1 (ATCC, Manassas, VA) with primers 5'-CGAGCAGCTTTTAATACAGGG-3' (forward) and 5'-GACACTAAGAACCTGAAGAGACCC-3' (reverse). The probes were labeled with {alpha}32P-dCTP by using the Rediprime II random prime or Megaprime DNA labeling systems (Amersham Pharmacia Biotech, Piscataway, NJ).

Statistical analysis
The significance of the differences between the 2 iron-treated groups and their respective controls was analyzed by two-factor analysis of variance with interaction. Significance was set at P < 0.05.


    RESULTS
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
Transport experiments
Before all the experiments, Caco-2 cell monolayers were treated for 24, 72, or 168 h with media containing various amounts of iron in the presence or the absence of serum, as described above. The resistance across the monolayers was not significantly different among groups. Intracellular iron concentrations were significantly greater in cells treated with MEM + Fe than in those treated with MEM (0.133 ± 0.003 and 0.038 ± 0.001 µg Fe/L, respectively) and significantly greater in cells treated with MEM + FBS + Fe than in those treated with MEM + FBS (0.266 ± 0.009 and 0.044 ± 0.001 µg Fe/L, respectively) at 168 h.

Both the uptake and the transepithelial movement of iron by cells treated with the iron-supplemented media (MEM + Fe and MEM + FBS + Fe) were {approx}50% of those of their respective controls (MEM and MEM + FBS) at 72 and 168 h (Figures 1 and 2GoGo). However, neither the uptake nor the transepithelial movement of iron was affected 24 h after iron supplementation. The response to iron supplementation was not dependent on the presence of serum. The effects of iron supplementation on the uptake and the transepithelial movement of manganese were similar to those on the uptake and transepithelial movement of iron. The uptake of manganese was less than that of iron, but transepithelial movement was greater (Figure 1Go). Transepithelial movement of zinc across the Caco-2 cell monolayers was lower than that of iron and manganese. Zinc uptake was slightly lower with supplementation in the absence of serum but the difference was not significant. In the presence of serum, iron supplementation was associated with significantly lower zinc uptake. The absence of serum had no significant effect on zinc movement across iron-supplemented Caco-2 cells. However, in the presence of serum, iron supplementation was associated with increased zinc movement from the apical to basolateral compartment. This occurred despite reduced cellular uptake of zinc under these conditions.



View larger version (14K):
[in this window]
[in a new window]
 
FIGURE 1. . Uptake of iron, manganese, and zinc into Caco-2 cells after 3 h of incubation at 37oC in the presence of 20 µmol 59Fe2+, 54Mn2+, or 65Zn2+/L and 2 mmol L-ascorbate/L in the apical chamber and 20 µmol human apotransferrin/L in the basolateral chamber. Before the transport experiments, the monolayers were allowed to differentiate for 21 d and then treated for 72 h in serum-free minimum essential medium (MEM), iron-supplemented MEM (MEM + Fe), serum-containing medium (MEM + FBS), or iron-supplemented, serum-containing medium (MEM + FBS + Fe) as described in Materials and Methods (24- and 168-h data not shown). The data are means ± SDs of 5–6 monolayers obtained from 2 separate experiments. aSignificantly different from MEM, P < 0.05. bSignificantly different from MEM + FBS, P < 0.05.

 


View larger version (10K):
[in this window]
[in a new window]
 
FIGURE 2. . Transepithelial movement of iron across monolayers of Caco-2 cells incubated for 3 h at 37oC in the presence of 20 µmol 59Fe2+/L and 2 mmol L-ascorbate/L in the apical chamber and 20 µmol human apotransferrin/L in the basolateral chamber. Before the transport experiments the monolayers were allowed to differentiate for 21 d and then treated for 168 h in serum-free minimum essential medium (MEM; {circ}), iron-supplemented MEM (MEM + Fe; •), serum-containing medium (MEM + FBS; {triangleup}), or iron-supplemented, serum-containing medium (MEM + FBS + Fe; {blacktriangleup}) as described in Materials and Methods (24- and 72-h data not shown). The data are means ± SDs of 5–6 monolayers obtained from 2 separate experiments. aSignificantly different from MEM, P < 0.05. bSignificantly different from MEM + FBS, P < 0.05.

 
Gene expression studies
The relative gene expression of DMT1, HFE, and SFT was measured by using northern hybridization to RNA extracted from Caco-2 cells treated similarly to those in the transport experiments. TfR expression was generally low and was detected only in cells grown in the presence of serum. Under these conditions, iron treatment decreased TfR expression to 58%, 36%, and 35% of that of the control after 24, 72, and 168 h, respectively (Figure 3Go). Iron supplementation decreased DMT1 expression by 50% under serum-free conditions. Similar to the transport studies, this effect was not present until after 24 h of treatment. In the presence of serum, DMT1 expression was unchanged by iron supplementation at all time points. HFE expression was detectable only in Caco-2 cells treated with serum-containing media. Supplementation of the cell culture medium with iron did not alter the expression of HFE at any of the time points. SFT was expressed in both MEM and MEM + FBS. Iron supplementation under either of these conditions did not affect SFT gene expression.



View larger version (27K):
[in this window]
[in a new window]
 
FIGURE 3. . Gene expression of divalent metal transporter 1 (DMT1), HFE, stimulator of iron transport (SFT), and transferrin receptor (TfR) in Caco-2 cells treated for 72 h in serum-free minimum essential medium (MEM), iron-supplemented MEM (MEM + Fe), serum-containing medium (MEM + FBS), or iron-supplemented, serum-containing medium (MEM + FBS + Fe) as described in Materials and Methods. Total RNA was isolated from the Caco-2 cells and analyzed for DMT1, HFE, SFT, and TfR mRNA by using northern hybridizations and phosphor-imaging. Gene expression values were normalized for glyceraldehyde 3-phosphate dehydrogenase (GAPDH) expression and expressed in units relative to controls.

 

    DISCUSSION
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
In the present study, the iron status of Caco-2 cells was modulated and correlations were sought between metal transport and expression of several genes implicated in iron metabolism. Intracellular iron status was determined by direct measurement and by assessing the regulation of TfR gene expression. Similar to the findings of others, we found that iron supplementation reduced iron uptake (21, 22). Our results also showed that uptakes of manganese and zinc were reduced by iron supplementation of Caco-2 cells. However, the reduction with zinc was only moderate.

DMT1 expressed in Xenopus oocytes was shown to transport divalent metal ions, including iron, manganese, and zinc (5). DMT1 was implicated in intestinal iron absorption when it was identified as the gene mutated in the microcytic anemia (mk) mouse and the phenotypically similar Belgrade (b) rat (6, 9, 23). In these 2 animal strains, orthologous mutations (Gly185Arg) in the DMT1 gene results in severely reduced absorption of dietary iron.

Our results showed that the expression of DMT1 is down-regulated by iron in the absence of serum. The down-regulation of DMT1 correlated with a decreased uptake of iron into Caco-2 cells. The changes in DMT1 expression we observed were small compared with those observed in vivo under iron-deficient conditions but were similar in magnitude to the changes in TfR. Alternative splice forms of DMT1 that differ in the carboxy terminal amino acids and the 3'-untranslated region have been identified. One of these transcripts contains a sequence consistent with an IRE similar to those found in the 3'-untranslated region of TfR (5, 24). In vivo studies showed that the putative IRE-containing transcript predominates in intestine and that this form is up-regulated in iron deficiency. In addition, the 5' flanking region of the DMT1 gene contains several sequences consistent with metal regulatory elements. The posttranscriptional regulation of TfR mediated by the binding of iron regulatory proteins to multiple IREs in the TfR transcript has been well established. Whether the regulation of DMT1 expression in vivo or in vitro is mediated through promoter elements, IRE binding, or both has yet to be determined. In fact, in vitro data show that DMT1 expression does not necessarily correlate with iron regulatory protein binding activity (25).

Our study also showed that iron treatment in the presence of serum decreased cellular iron uptake, which was not accompanied by a decrease in DMT1 expression. This suggests either that DMT1 is posttranscriptionally modified at high intracellular iron concentrations or that other transporters are involved.

In addition to uptake, the transepithelial movement of iron across the Caco-2 cells was significantly reduced by iron treatment. The same effect was observed for manganese, suggesting that the mechanism by which intestinal iron is absorbed into the circulation is operative for manganese as well. However, the transepithelial movement of zinc was not affected by iron supplementation under serum-free conditions, suggesting that this step is mediated by a separate mechanism. This is consistent with the recent finding that absorption of zinc requires specific zinc transporters to facilitate efflux from enterocytes (26). In contrast, we found that transepithelial movement of zinc was significantly increased by iron supplementation in the presence of serum. One possibility is that high intracellular iron induces these zinc transporters.

The results of ferrokinetic studies suggest that HFE is involved in the transport of iron across the basolateral membrane of the enterocyte. The identification of HFE as the mutated gene responsible for hereditary hemochromatosis constitutes an important piece of the iron regulatory puzzle (1). Interestingly, it has been shown that the expression of DMT1 is up-regulated in the intestines of persons with hereditary hemochromatosis and in HFE-knockout mice (7, 8). In the present study, we found that serum is required for HFE expression in Caco-2 cells. Han et al (27) reported previously that HFE is up-regulated by iron loading and down-regulated by iron depletion in Caco-2 cells, suggesting reciprocal regulation with DMT1. In contrast, our experiments did not show any effects of iron supplementation on HFE expression. One potential explanation for these different results is the stage of differentiation. Whereas Han et al used cells that were 13 d postconfluent, we used fully differentiated cells that were 21 d postconfluent.

Although it remains unclear whether the novel iron transport gene SFT plays a role in the regulation of dietary iron absorption, the results of the present study show that the SFT gene is present in Caco-2 cells. However, no differences were observed in gene expression as a result of iron supplementation to the media.

In conclusion, iron treatment in both the presence and the absence of serum resulted in a decreased uptake of iron and manganese and, in the presence of serum, of zinc into Caco-2 cells, but only in the absence of serum did this effect correlate with DMT1 expression. Otherwise, correlations between the uptake and the transepithelial movement of iron and the gene expression of DMT1, HFE, or SFT in Caco-2 cells were not observed, indicating that these genes are regulated posttranscriptionally or that other genes are involved. Genes not investigated in this study, including heme oxygenase 1 and hephaestin, may be involved in the regulation of uptake and transepithelial movement of iron (28, 29). Further investigations are needed to determine the mechanism by which DMT1 expression is regulated by intracellular iron and to identify other genes that may be involved in the regulation of iron absorption.


    ACKNOWLEDGMENTS
 
We acknowledge the technical assistance of Melissa Crawford, Department of Internal Medicine, University of California Davis.


    REFERENCES
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 

  1. Feder JN, Gnirke A, Thomas W, et al. A novel MHC class I-like gene is mutated in patients with hereditary hemochromatosis. Nat Genet 1996;13:399–408.[Medline]
  2. Hirsch EC. Biochemistry of Parkinson's disease with special reference to the dopaminergic systems. Mol Neurol 1997;94:135–42.
  3. Dinneen SF, Silverberg JD, Batts KP, et al. Liver iron stores in patients with non-insulin dependent diabetes mellitus. Mayo Clin Proc 1994;69:13–5.[Medline]
  4. Nelson RL, Davis FG, Persky V, Becker E. Risk of neoplastic and other diseases among people with heterozygosity for hereditary hemochromatosis. Cancer 1995;76:875–9.[Medline]
  5. Gunshin H, Mackenzie B, Berger UV, et al. Cloning and characterization of a mammalian proton-coupled metal-ion transporter. Nature 1997;388:482–7.[Medline]
  6. Fleming MD, Trenor CC III, Su MA, et al. Microcytic anemia mice have a mutation in Nramp2, a candidate iron transporter gene. Nat Genet 1997;16:383–6.[Medline]
  7. Fleming RE, Migas MC, Zhou X, et al. Mechanism of increased iron absorption in murine model of hereditary hemochromatosis: increased duodenal expression of the iron transporter DMT1. Proc Natl Acad Sci U S A 1999;96:3143–8.[Abstract/Free Full Text]
  8. Zoller H, Pietrangelo A, Vogel W, Weiss G. Duodenal metal-transporter (DMT1, Nramp-2) expression in patients with hereditary hemochromatosis. Lancet 1999;353:2120–3.[Medline]
  9. Fleming MD, Romano MA, Su MA, Garrick LM, Garrick MD, Andrews NC. Nramp-2 is mutated in the anemic Belgrade (b) rat: evidence of a role for Nramp-2 in endosomal iron transport. Proc Natl Acad Sci U S A 1998;95:1148–53.[Abstract/Free Full Text]
  10. Feder JN, Penny DM, Irrinki A, et al. The hemochromatosis gene product complexes with the transferrin receptor and lowers its affinity for ligand binding. Proc Natl Acad Sci U S A 1998;95:1472–7.[Abstract/Free Full Text]
  11. Parkkila S, Waheed A, Britton RS, et al. Association of the transferrin receptor in human placenta with HFE, the protein defective in hereditary hemochromatosis. Proc Natl Acad Sci U S A 1997;94: 13198–202.[Abstract/Free Full Text]
  12. Waheed A, Parkkila S, Saarnio J, et al. Association of HFE protein with transferrin receptor in crypt enterocytes of human duodenum. Proc Natl Acad Sci U S A 1999;96:1579–84.[Abstract/Free Full Text]
  13. Gutierrez JA, Yu J, Rivera S, Wessling-Resnick M. Functional expression cloning and characterization of SFT, a stimulator of Fe transport. J Cell Biol 1997;139:895–905.[Abstract/Free Full Text]
  14. Gutierrez JA, Yu J, Wessling-Resnick M. Characterization and chromosomal mapping of the human gene for SFT, a stimulator of Fe transport. Biochem Biophys Res Com 1998;253:739–42.[Medline]
  15. Morgan EH. Membrane transport of non-transferrin bound iron by reticulocytes. Biochim Biophys Acta 1988;943:428–39.[Medline]
  16. Yu J, Zhong Kang Y, Wessling-Resnick M. Expression of SFT (stimulator of Fe transport) is enhanced by iron chelation in HeLa cells and by hemochromatosis in liver. J Biol Chem 1998;273:34675–8.[Abstract/Free Full Text]
  17. Golub MS, Han B, Keen CL. Developmental patterns of aluminum and five essential mineral elements in the central nervous system of the fetal and infant guinea pig. Biol Trace Elem Res 1996;55:241–51.[Medline]
  18. Tallkvist J, Tjälve H. Transport of nickel across monolayers of human intestinal Caco-2 cells. Toxicol Appl Pharmacol 1998;151:117–22.[Medline]
  19. Artursson P, Karlsson J, Ocklind G, Schipper N. Studying transport processes in absorptive epithelia. In: Shaw A, ed. Epithelial cell culture. New York: Oxford Press, 1996:111–33.
  20. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987;162:156–9.[Medline]
  21. Alvarez-Hernandez X, Nichols GM, Glass J. Caco-2 cell line: a system for studying intestinal transport across epithelial cell monolayers. Biochim Biophys Acta 1991;1070:205–8.[Medline]
  22. Arredondo M, Orellana A, Garate MA, Nunez MT. Intracellular iron regulates iron absorption and IRP activity in intestinal epithelial (Caco-2) cells. Am J Physiol 1997;273:205–8.
  23. Su MA, Trenor CC III, Fleming JC, Fleming MD, Andrews NC. The G185R mutation disrupts function of the iron transporter Nramp-2. Blood 1998;92:2157–63.[Abstract/Free Full Text]
  24. Lee PL, Gelbart T, West C, Halloran C, Beutler E. The human Nramp2 gene: characterization of the gene structure, alternative splicing, promoter region and polymorphisms. Blood Cells Mol Dis 1998;24:199–215.[Medline]
  25. Wardrop SL, Richardson DR. The effect of intracellular iron concentration and nitrogen monoxide on Nramp2 expression and non-transferrin-bound iron uptake. Eur J Biochem 1999;263:41–9.[Medline]
  26. Reyes JG. Zinc transport in mammalian cells. Am J Physiol 1996; 270:401–10.
  27. Han O, Fleet JC, Wood RJ. Reciprocal regulation of HFE and Nramp-2 gene expression by iron in human intestinal cells. J Nutr 1999;129:98–104.[Abstract/Free Full Text]
  28. Poss KD, Tonegawa S. Heme oxygenase 1 is required for mammalian iron reutilization. Proc Natl Acad Sci U S A 1997;94:10919–24.[Abstract/Free Full Text]
  29. Vulpe CD, Kuo YM, Murphy TL, et al. Hephaestin, a ceruloplasmin homologue implicated in intestinal iron transport, is defective in the sla mouse. Nat Genet 1999;21:195–9.[Medline]
Received for publication July 16, 1999. Accepted for publication March 28, 2000.




This article has been cited by other articles:


Home page
J. Nutr.Home page
S. L. Kelleher and B. Lonnerdal
Zinc Supplementation Reduces Iron Absorption through Age-Dependent Changes in Small Intestine Iron Transporter Expression in Suckling Rat Pups
J. Nutr., May 1, 2006; 136(5): 1185 - 1191.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
K. Kordas and R. J. Stoltzfus
New Evidence of Iron and Zinc Interplay at the Enterocyte and Neural Tissues
J. Nutr., June 1, 2004; 134(6): 1295 - 1298.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
P. G. Reeves, N. V. C. Ralston, J. P. Idso, and H. C. Lukaski
Contrasting and Cooperative Effects of Copper and Iron Deficiencies in Male Rats Fed Different Concentrations of Manganese and Different Sources of Sulfur Amino Acids in an AIN-93G-Based Diet
J. Nutr., February 1, 2004; 134(2): 416 - 425.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
D. L. de Romana, B. Lonnerdal, and K. H Brown
Absorption of zinc from wheat products fortified with iron and either zinc sulfate or zinc oxide
Am. J. Clinical Nutrition, August 1, 2003; 78(2): 279 - 283.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
J. R. Follett, Y. A. Suzuki, and B. Lonnerdal
High specific activity heme-Fe and its application for studying heme-Fe metabolism in Caco-2 cell monolayers
Am J Physiol Gastrointest Liver Physiol, November 1, 2002; 283(5): G1125 - G1131.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
C. Thomas and P. S. Oates
IEC-6 Cells Are an Appropriate Model of Intestinal Iron Absorption in Rats
J. Nutr., April 1, 2002; 132(4): 680 - 687.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
J. Beard
Iron treatment and human intestinal Caco-2 cells
Am. J. Clinical Nutrition, September 1, 2000; 72(3): 677 - 678.
[Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tallkvist, J.
Right arrow Articles by Lönnerdal, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tallkvist, J.
Right arrow Articles by Lönnerdal, B.
Agricola
Right arrow Articles by Tallkvist, J.
Right arrow Articles by Lönnerdal, B.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS